Advertisement
Review Article| Volume 16, ISSUE 2, P70-78, April 2007

Download started.

Ok

Delayed Contrast Enhancement Magnetic Resonance Imaging for the Assessment of Cardiac Disease

      Cardiovascular magnetic resonance imaging (CMR) with delayed contrast enhancement (DCE) using Gadolinium based contrast media is a recently developed technique which allows the direct visualisation of myocardial necrosis or fibrosis as regions of bright signal (hyperenhancement) compared with normal myocardium. The manuscript presents a review of the current clinical application of DCE–CMR for the diagnosis and prognosis of various common cardiac conditions such as ischaemic and non-ischaemic cardiomyopathies, and less common diseases such as cardiac sarcoidosis or Löffler endocarditis (Table 1).

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Simonetti O.P.
        • Kim R.J.
        • Fieno D.S.
        • Hillenbrand H.B.
        • Wu E.
        • Bundy J.M.
        • Finn J.P.
        • Judd R.M.
        An improved MR imaging technique for the visualization of myocardial infarction.
        Radiology. 2001; 218: 215-223
        • Pennell D.J.
        • Sechtem U.P.
        • Higgins C.B.
        • Manning W.J.
        • Pohost G.M.
        • Rademakers F.E.
        • van Rossum A.C.
        • Shaw L.J.
        • Yucel E.K.
        Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.
        Eur Heart J. 2004; 25: 1940-1965
        • Weinmann H.J.
        • Brasch R.C.
        • Press W.R.
        • Wesbey G.E.
        Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
        Am J Roentgenol. 1984; 142: 619-624
        • Lima J.A.
        • Judd R.M.
        • Bazille A.
        • Schulman S.P.
        • Atalar E.
        • Zerhouni E.A.
        Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.
        Circulation. 1995; 92: 1117-1125
        • Kim R.J.
        • Shah D.J.
        • Judd R.M.
        How we perform delayed enhancement imaging.
        J Cardiovasc Magn Reson. 2003; 5: 505-514
        • Kim R.J.
        • Wu E.
        • Rafael A.
        • Chen E.L.
        • Parker M.A.
        • Simonetti O.
        • Klocke F.J.
        • Bonow R.O.
        • Judd R.M.
        The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
        N Engl J Med. 2000; 343: 1445-1453
        • Thomson L.E.
        • Kim R.J.
        • Judd R.M.
        Magnetic resonance imaging for the assessment of myocardial viability.
        J Magn Reson Imaging. 2004; 19: 771-788
      1. Heart disease and stroke statistics—2006 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2006;113:85–151.

        • Taylor G.J.
        • Humphries J.
        • Mellits E.D.
        • Pitt B.
        • Schulze R.A.
        • Griffith L.S.
        • Achuff S.C.
        Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction.
        Circulation. 1980; 62: 960-970
        • Mock M.B.
        • Ringqvist I.
        • Fisher L.D.
        • Davis K.B.
        • Chaitman B.R.
        • Kouchoukos N.T.
        • Kaiser G.C.
        • Alderman E.
        • Ryan T.J.
        • Russell Jr., R.O.
        • Mullin S.
        • Fray D.
        • Killip III, T.
        Survival of medically treated patients in the coronary artery surgery study (CASS) registry.
        Circulation. 1982; 66: 562-568
        • Sheehan F.H.
        Determinants of improved left ventricular function after thrombolytic therapy in acute myocardial infarction.
        J Am Coll Cardiol. 1987; 9: 937-944
        • Lewis S.J.
        • Sawada S.G.
        • Ryan T.
        • Segar D.S.
        • Armstrong W.F.
        • Feigenbaum H.
        Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium.
        Am Heart J. 1991; 121: 1088-1094
        • Heyndrickx G.R.
        • Millard R.W.
        • McRitchie R.J.
        • Maroko P.R.
        • Vatner S.F.
        Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.
        J Clin Invest. 1975; 56: 978-985
        • Rahimtoola S.H.
        The hibernating myocardium.
        Am Heart J. 1989; 117: 211-221
        • Gropler R.J.
        • Bergman S.R.
        Myocardial viability—what is the definition?.
        J Nucl Med. 1991; 32: 10-12
        • Di Carli M.F.
        • Davidson M.
        • Little R.
        • Khanna S.
        • Mody F.V.
        • Brunken R.C.
        • Czernin J.
        • Rokhsar S.
        • Stevenson L.W.
        • Laks H.
        • Hawkins R.
        • Schelbert H.R.
        • Phelps M.E.
        • Maddahi J.
        Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.
        Am J Cardiol. 1994; 73: 527-533
        • Eitzman D.
        • al-Aouar Z.
        • Kanter H.L.
        • vom Dahl J.
        • Kirsh M.
        • Deeb G.M.
        • Schwaiger M.
        Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.
        J Am Coll Cardiol. 1992; 20: 559-565
        • Marwick T.H.
        • Nemec J.J.
        • Lafont A.
        • Salcedo E.E.
        • MacIntyre W.J.
        Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization.
        Am J Cardiol. 1992; 69: 854-859
        • Allman K.C.
        • Shaw L.J.
        • Hachamovitch R.
        • Udelson J.E.
        Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
        J Am Coll Cardiol. 2002; 39: 1151-1158
        • Kim R.J.
        • Chen E.L.
        • Lima J.A.
        • Judd R.M.
        Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.
        Circulation. 1996; 94: 3318-3326
        • McNamara M.T.
        • Tscholakoff D.
        • Revel D.
        • Soulen R.
        • Schechtmann N.
        • Botvinick E.
        • Higgins C.B.
        Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA.
        Radiology. 1986; 158: 765-769
        • Judd R.M.
        • Lugo-Olivieri C.H.
        • Arai M.
        • Kondo T.
        • Croisille P.
        • Lima J.A.
        • Mohan V.
        • Becker L.C.
        • Zerhouni E.A.
        Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.
        Circulation. 1995; 92: 1902-1910
        • Rochitte C.E.
        • Lima J.A.
        • Bluemke D.A.
        • Reeder S.B.
        • McVeight E.R.
        • Furuta T.
        • Becker L.C.
        • Melin J.A.
        Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.
        Circulation. 1998; 98: 1006-1014
        • Saeed M.
        • Lund G.
        • Wendland M.F.
        • Bremerich J.
        • Weinmann H.
        • Higgins C.B.
        Magnetic resonance characterization of the peri-infarct zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.
        Circulation. 2001; 103: 871-876
        • Ingkanisorn W.P.
        • Rhoads K.L.
        • Aletras A.H.
        • Kellman P.
        • Arai A.E.
        Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction.
        J Am Coll Cardiol. 2004; 43: 2253-2599
        • Wu K.C.
        • Zerhouni E.A.
        • Judd R.M.
        • Lugo-Olivieri C.H.
        • Barouch L.A.
        • Schulman S.P.
        • Blumenthal R.S.
        • Lima J.A.
        Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.
        Circulation. 1998; 97: 765-772
        • Underwood S.R.
        • Bax J.J.
        • vom Dahl J.
        • Henein M.Y.
        • Knuuti J.
        • van Rossum A.C.
        • Schwarz E.R.
        • Vanoverschelde J.L.
        • van der Wall E.E.
        • Wijns W.
        Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology.
        Eur Heart J. 2004; 25: 815-836
        • Gerber B.L.
        • Garot J.
        • Bluemke D.A.
        • Wu K.C.
        • Lima J.A.
        Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.
        Circulation. 2002; 106: 1083-1089
        • Beek A.M.
        • Kuhl H.P.
        • Bondarenko O.
        • Twisk J.W.
        • Hofman M.B.
        • van Dockum W.G.
        • Visser C.A.
        • van Rossum A.C.
        Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction.
        J Am Coll Cardiol. 2003; 42: 895-901
        • Selvanayagam J.B.
        • Kardos A.
        • Francis J.M.
        • Wiesmann F.
        • Petersen S.E.
        • Taggart D.P.
        • Neubauer S.
        Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.
        Circulation. 2004; 110: 1535-1541
        • Kim R.J.
        • Shah D.J.
        Fundamental concepts in myocardial viability assessment revisited: when knowing how much is “alive” is not enough.
        Heart. 2004; 90: 137-140
        • Bello D.
        • Shah D.J.
        • Farah G.M.
        • Di Luzio S.
        • Parker M.
        • Johnson M.R.
        • Cotts W.G.
        • Klocke F.J.
        • Bonow R.O.
        • Judd R.M.
        • Gheorghiade M.
        • Kim R.J.
        Gadolinium Cardiovascular Magnetic Resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing ß-blocker therapy.
        Circulation. 2003; 108: 1945-1953
        • Bellenger N.G.
        • Rajappan K.
        • Rahman S.L.
        • Lahiri A.
        • Ravul U.
        • Webster J.
        • Murray G.D.
        • Coats A.J.
        • Cleland J.G.
        • Pennell D.J.
        • CHRISTMAS Study Steering Committee and Investigators
        Effects of carvedilol on left ventricular remodeling in chronic stable heart failure: a cardiovascular magnetic resonance study.
        Heart. 2004; 90: 760-764
        • Bellenger N.G.
        • Davies L.C.
        • Francis J.M.
        • Coats A.J.
        • Pennell D.J.
        Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.
        J Cardiovasc Magn Reson. 2000; 2: 271-278
        • Ramani K.
        • Judd R.M.
        • Holly T.A.
        • Parrish T.B.
        • Rigolin V.H.
        • Parker M.A.
        • Callahan C.
        • Fitzgerald S.W.
        • Bonow R.O.
        • Klocke F.J.
        Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.
        Circulation. 1998; 98: 2687-2694
        • Wagner A.
        • Mahrholdt H.
        • Holly T.A.
        • Elliott M.D.
        • Regenfus M.
        • Parker M.
        • Klocke F.J.
        • Bonow R.O.
        • Kim R.J.
        • Judd R.M.
        Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.
        Lancet. 2003; 361: 374-379
        • Klein C.
        • Nekolla S.G.
        • Bengel F.M.
        • Momose M.
        • Sammer A.
        • Haas F.
        • Schnackenburg B.
        • Delius W.
        • Mudra H.
        • Wolfram D.
        • Schwaiger M.
        Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Comparison with positron emission tomography.
        Circulation. 2002; 105: 162-167
        • Kuhl H.P.
        • Beek A.M.
        • van der Weerdt A.P.
        • Hofman M.B.
        • Visser C.A.
        • Lammertsma A.A.
        • Heussen N.
        • Visser F.C.
        • van Rossum A.C.
        Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
        J Am Coll Cardiol. 2003; 41: 1341-1348
        • Knuesel P.R.
        • Nanz D.
        • Wyss C.
        • Buechi M.
        • Kaufmann P.A.
        • von Schulthess G.K.
        • Luscher T.F.
        • Schwitter J.
        Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization.
        Circulation. 2003; 108: 1095-1100
        • Kuhl H.P.
        • Lipke C.S.
        • Krombach G.A.
        • Katoh M.
        • Battenberg T.F.
        • Nowak B.
        • Heussen N.
        • Buecker A.
        • Schaefer W.M.
        Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
        Eur Heart J. 2006; 27: 846-853
        • Srichai M.B.
        • Junor C.
        • Rodriguez L.L.
        • Stillman A.E.
        • Grimm R.A.
        • Lieber M.L.
        • Weaver J.A.
        • Smedira N.G.
        • White R.D.
        Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation.
        Am Heart J. 2006; 152: 75-84
        • Richardson P.
        • McKenna W.
        • Bristow M.
        Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies.
        Circulation. 1996; 93: 841-842
        • Bender J.R.
        Idiopathic dilated cardiomyopathy. An immunologic, genetic or infectious disease, or all of the above?.
        Circulation. 1991; 83: 704-706
        • Wu E.
        • Judd R.M.
        • Vargas J.
        Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
        Lancet. 2001; 357: 21-28
        • McCrohon J.A.
        • Moon J.C.
        • Prasad S.K.
        Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
        Circulation. 2003; 108: 54-59
        • Roberts W.C.
        • Siegel R.J.
        • McManus B.M.
        Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.
        Am J Cardiol. 1987; 60: 1340-1355
        • Assomul R.G.
        • Prasad S.K.
        • Burmna E.
        Cardiovascular magnetic resonance, fibrosis and prognosis in dilated cardiomyopathy.
        J Cardiovasc Magn Reson. 2006; 8 ([abstract]): 3-4
        • Wynne J.
        • Braunwald E.
        Hypertrophic Cardiomyopathy.
        in: Zipes D.P. Libby P. Bonow R.O. Braunwald E. Braunwald's Heart Disease: a textbook of cardiovascular medicine. Elsevier Saunders, Philadelphia, Pennsylvania2005: 1667-1682
        • Choudhury L.
        • Mahrholdt H.
        • Wagner A.
        • Choi K.M.
        • Elliott M.D.
        • Klocke F.J.
        • Bonow R.O.
        • Judd R.M.
        • Kim R.J.
        Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2002; 40: 2156-2164
        • Moon J.C.
        • McKenna W.J.
        • McCrohon J.A.
        • Elliott P.M.
        • Smith G.C.
        • Pennell D.J.
        Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
        J Am Coll Cardiol. 2003; 41: 1561-1567
        • van Dockum W.G.
        • Ten Cate F.J.
        • Ten Berg J.M.
        • Beek A.M.
        • Twisk J.W.
        • Vos J.
        • Hofman M.B.
        • Visser C.A.
        • van Rossum A.C.
        Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
        J Am Coll Cardiol. 2004; 43: 27-34
        • van Dockum W.G.
        • Beek A.M.
        • Ten Cate F.J.
        • Ten Berg J.M.
        • Bondarenko O.
        • Gotte M.J.
        • Twisk J.W.
        • Hofman M.B.
        • Visser C.A.
        • van Rossum A.C.
        Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
        Circulation. 2005; 111: 2503-2508
        • Moon J.C.
        • Sachdev B.
        • Elkington A.G.
        • McKenna W.J.
        • Mehta A.
        • Pennell D.J.
        • Leed P.J.
        • Elliott P.M.
        Gadolinium enhanced cardiovascular magnetic resonance in Anderson–Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.
        Eur Heart J. 2003; 24: 2151-2155
        • Gemayel C.
        • Pelliccia A.
        • Thompson P.D.
        Arrhythmogenic right ventricular cardiomyopathy.
        J Am Coll Cardiol. 2001; 38: 1773-1781
        • Tandri H.
        • Saranathan M.
        • Rodriguez E.R.
        • Martinez C.
        • Bomma C.
        • Nasir K.
        • Rosen B.
        • Lima J.A.
        • Calkins H.
        • Bluemke D.A.
        Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.
        J Am Coll Cardiol. 2005; 45: 98-103
        • McKenna W.J.
        • Thiene G.
        • Nava A.
        • Fontaliran F.
        • Blomstrom-Lundqvist C.
        • Fontaine G.
        • Camerini F.
        • and Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology
        Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
        Br Heart J. 1994; 71: 215-218
        • Aretz H.T.
        • Billingham M.E.
        • Edwards W.D.
        • Factor S.M.
        • Fallon J.T.
        • Fenoglio Jr., J.J.
        • Olsen E.G.
        • Schoen F.J.
        Myocarditis: a histopathologic definition and classification.
        Am J Cardiovasc Pathol. 1987; 1: 3-14
        • Friedrich M.G.
        • Strohm O.
        • Schulz-Menger J.
        Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis.
        Circulation. 1998; 97: 1802-1809
        • Mahrholdt H.
        • Goedecke C.
        • Wagner A.
        Cardiovascular magnetic resonance assessment of human myocarditis; a comparison to histology and molecular pathology.
        Circulation. 2004; 109: 1250-1258
        • Silverman K.J.
        • Hutchins G.M.
        • Bulkley B.H.
        Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.
        Circulation. 1978; 58: 1204-1211
        • Mahrholdt H.
        • Wagner A.
        • Judd R.M.
        • Sechtem U.
        • Kim R.J.
        Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
        Eur Heart J. 2005; 26: 1461-1474
        • Abeler V.
        Sarcoidosis of the cardiac conducting system.
        Am Heart J. 1979; 97: 701-707
        • Sharma O.P.
        Cardiac and neurologic dysfunction in sarcoidosis.
        Clin Chest Med. 1997; 18: 813-825
        • Shimada T.
        • Shimada K.
        • Sakane T.
        • Ochiai K.
        • Tsukihashi H.
        • Fukui M.
        • Inoue S.
        • Katoh H.
        • Murakami Y.
        • Ishibashi Y.
        • Maruyama R.
        Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.
        Am J Med. 2001; 110: 520-527
        • Vignaux O.
        • Dhote R.
        • Duboc D.
        • Blanche P.
        • Dusser D.
        • Weber S.
        • Legmann P.
        Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study.
        Chest. 2002; 122: 1895-1901
        • Yazaki Y.
        • Isobe M.
        • Hiroe M.
        • Morimoto S.
        • Hiramitsu S.
        • Nakano T.
        • Izumi T.
        • Sekiguchi M.
        • Central Japan Heart Study Group
        Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.
        Am J Cardiol. 2001; 88: 1006-1010
        • Wynne J.
        • Braunwald E.
        Restrictive and infiltrative cardiomyopathies.
        in: Zipes D.P. Libby P. Bonow R.O. Braunwald E. Braunwald's heart disease: a textbook of cardiovascular medicine. Elsevier Saunders, Philadelphia, Pennsylvania2005: 1682-1692
        • Maceira A.M.
        • Joshi J.
        • Prasad S.K.
        • Moon J.C.
        • Perugini E.
        • Harding I.
        • Sheppard M.N.
        • Poole-Wilson P.A.
        • Hawkins P.N.
        • Pennell D.J.
        Cardiovascular magnetic resonance in cardiac amyloidosis.
        Circulation. 2005; 111: 186-193
        • Bogaert J.
        • Taylor A.M.
        Nonischemic myocardial disease.
        in: Bogart J. Dymarkowski S. Taylor A.M. Clinical cardiac MRI. Springer, Berlin, Germany2005: 217-271
        • Rochitte C.E.
        • Oliveria P.F.
        • Andrade J.M.
        • Ianni B.M.
        • Parga J.R.
        • Avila L.F.
        • Kalil-Filho R.
        • Mady C.
        • Meneghetti J.C.
        • Lima J.A.
        • Ramires J.A.
        Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity.
        J Am Coll Cardiol. 2005; 46: 1553-1558
        • Katz J.
        • Whang J.
        • Boxt L.M.
        • Barst R.J.
        Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.
        J Am Coll Cardiol. 1993; 21: 1475-1481
        • Boxt L.M.
        • Katz J.
        • Kolb T.
        • Czegledy F.P.
        • Barst R.J.
        Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension.
        J Am Coll Cardiol. 1992; 19: 1508-1515
        • Kroft L.J.M.
        • Simons P.
        • van Laar J.M.
        • de Roos A.
        Patients with pulmonary fibrosis: cardiac function assessed with MR imaging.
        Radiology. 2000; 216: 464-471
        • Blyth K.G.
        • Groenning B.A.
        • Martin T.N.
        • Foster J.A.
        • Mark P.B.
        • Dargie H.J.
        • Peacock A.J.
        Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.
        Eur Heart J. 2005; 26: 1993-1999